BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03976375-completion@plaintrial.com
DTSTAMP:20261029T034622Z
DTSTART;VALUE=DATE:20240822
SUMMARY:Efficacy and Safety of Pembrolizumab (MK-3475) With Lenvatinib (E70
 80/MK-7902) vs. Docetaxel in Participants With Metastatic Non-Small Cell L
 ung Cancer (NSCLC) and Progressive Disease (PD) After Platinum Doublet Che
 motherapy and Immunotherapy (MK-7902-008/E7080-G000-316/LEAP-008) — esti
 mated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT03976375
URL:https://plaintrial.com/trial/NCT03976375
END:VEVENT
END:VCALENDAR